麻豆传媒

CFTR modulator carries boxed warning over risk of drug-induced liver injury and liver failure

A conversation on living with cystic fibrosis and the threat of antimicrobial resistance

Repeated BAL-directed therapy with general anesthesia at young ages safer than once believed?

Magnitude of differences "substantially larger in children of Black race," researcher noted

A little-known microbe claimed Mallory Smith's life but did not quell her light

Lung function, BMI, bacterial swabs, sweat chloride levels also improved

Patients ages 2 to 5 years now eligible for the triple therapy

Presented with classic signs and symptoms, but still not tested

Accelerating trial enrollment can catalyze access to much-needed medications

Other frequent cardiac comorbidities included Afib and acute MI, real-world analysis shows

Another group of CF patients sees a win for triple therapy in phase III trial

Bioethicist and pediatrician debate cystic fibrosis gene-editing

CMS competitive bidding for durable medical equipment to blame, experts say

Study shows that randomized trials are feasible among those under 4 months